Institutional Repository of Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing 100190, Peoples R China
A Non-invasive Radiomic Method Using F-18-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With Glioma | |
Li, Longfei1,2; Mu, Wei2; Wang, Yaning3; Liu, Zhenyu2; Liu, Zehua1,2; Wang, Yu3; Ma, Wenbin3; Kong, Ziren3; Wang, Shuo2; Zhou, Xuezhi2,4; Wei, Wei2,4,5; Cheng, Xin6; Lin, Yusong1,7; Tian, Jie2,4,8,9 | |
发表期刊 | FRONTIERS IN ONCOLOGY |
ISSN | 2234-943X |
2019-11-14 | |
卷号 | 9页码:11 |
通讯作者 | Cheng, Xin(pumch_chengxin@126.com) ; Lin, Yusong(yslin@ha.edu.cn) ; Tian, Jie(jie.tian@ia.ac.cn) |
摘要 | Purpose: We aimed to analyze F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG PET) images via the radiomic method to develop a model and validate the potential value of features reflecting glioma metabolism for predicting isocitrate dehydrogenase (IDH) genotype and prognosis. Methods: PET images of 127 patients were retrospectively analyzed. A series of quantitative features reflecting the metabolic heterogeneity of the tumors were extracted, and a radiomic signature was generated using the support vector machine method. A combined model that included clinical characteristics and the radiomic signature was then constructed by multivariate logistic regression to predict the IDH genotype status, and the model was evaluated and verified by receiver operating characteristic (ROC) curves and calibration curves. Finally, Kaplan-Meier curves and log-rank tests were used to analyze overall survival (OS) according to the predicted result. Results: The generated radiomic signature was significantly associated with IDH genotype (p < 0.05) and could achieve large areas under the ROC curve of 0.911 and 0.900 on the training and validation cohorts, respectively, with the incorporation of age and type of tumor metabolism. The good agreement of the calibration curves in the validation cohort further validated the efficacy of the constructed model. Moreover, the predicted results showed a significant difference in OS between high- and low-risk groups (p < 0.001). Conclusions: Our results indicate that the F-18-FDG metabolism-related features could effectively predict the IDH genotype of gliomas and stratify the OS of patients with different prognoses. |
关键词 | F-18-FDG PET radiomics glioma isocitrate dehydrogenase non-invasive prediction |
DOI | 10.3389/fonc.2019.01183 |
关键词[WOS] | GRADE ; CLASSIFICATION ; ASTROCYTOMAS ; DIAGNOSIS ; ONCOLOGY ; SURVIVAL ; FEATURES ; SYSTEM ; ADULTS |
收录类别 | SCI |
语种 | 英语 |
资助项目 | National Natural Science Foundation of China[81772009] ; National Natural Science Foundation of China[81922040] ; National Natural Science Foundation of China[81772012] ; National Natural Science Foundation of China[81227901] ; National Key Research and Development Plan of China[2017YFA0205200] ; National Key Research and Development Plan of China[2016YFA0100900] ; National Key Research and Development Plan of China[2016YFA0100902] ; Scientific and Technological Research Project of Henan Province[182102310162] ; Beijing Natural Science Foundation[7182109] ; Chinese Academy of Sciences[GJJSTD20170004] ; Chinese Academy of Sciences[QYZDJ-SSW-JSC005] ; Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences[2016-I2M-2-001] ; Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences[2018-I2M-3-001] ; Fundamental Research Funds for the Central Universities[3332018029] ; Youth Innovation Promotion Association CAS[2019136] ; National Natural Science Foundation of China[81772009] ; National Natural Science Foundation of China[81922040] ; National Natural Science Foundation of China[81772012] ; National Natural Science Foundation of China[81227901] ; National Key Research and Development Plan of China[2017YFA0205200] ; National Key Research and Development Plan of China[2016YFA0100900] ; National Key Research and Development Plan of China[2016YFA0100902] ; Scientific and Technological Research Project of Henan Province[182102310162] ; Beijing Natural Science Foundation[7182109] ; Chinese Academy of Sciences[GJJSTD20170004] ; Chinese Academy of Sciences[QYZDJ-SSW-JSC005] ; Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences[2016-I2M-2-001] ; Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences[2018-I2M-3-001] ; Fundamental Research Funds for the Central Universities[3332018029] ; Youth Innovation Promotion Association CAS[2019136] |
项目资助者 | National Natural Science Foundation of China ; National Key Research and Development Plan of China ; Scientific and Technological Research Project of Henan Province ; Beijing Natural Science Foundation ; Chinese Academy of Sciences ; Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences ; Fundamental Research Funds for the Central Universities ; Youth Innovation Promotion Association CAS |
WOS研究方向 | Oncology |
WOS类目 | Oncology |
WOS记录号 | WOS:000501792200001 |
出版者 | FRONTIERS MEDIA SA |
七大方向——子方向分类 | 医学影像处理与分析 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.ia.ac.cn/handle/173211/29330 |
专题 | 中国科学院分子影像重点实验室 |
通讯作者 | Cheng, Xin; Lin, Yusong; Tian, Jie |
作者单位 | 1.Zhengzhou Univ, Collaborat Innovat Ctr Internet Healthcare, Zhengzhou, Henan, Peoples R China 2.Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing, Peoples R China 3.Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing, Peoples R China 4.Xidian Univ, Engn Res Ctr Mol & Neuro Imaging, Sch Life Sci & Technol, Minist Educ, Xian, Shaanxi, Peoples R China 5.Xian Polytech Univ, Sch Elect & Informat, Xian, Shaanxi, Peoples R China 6.Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China 7.Zhengzhou Univ, Sch Software, Zhengzhou, Henan, Peoples R China 8.Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing, Peoples R China 9.Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Beijing, Peoples R China |
第一作者单位 | 中国科学院自动化研究所 |
通讯作者单位 | 中国科学院自动化研究所 |
推荐引用方式 GB/T 7714 | Li, Longfei,Mu, Wei,Wang, Yaning,et al. A Non-invasive Radiomic Method Using F-18-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With Glioma[J]. FRONTIERS IN ONCOLOGY,2019,9:11. |
APA | Li, Longfei.,Mu, Wei.,Wang, Yaning.,Liu, Zhenyu.,Liu, Zehua.,...&Tian, Jie.(2019).A Non-invasive Radiomic Method Using F-18-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With Glioma.FRONTIERS IN ONCOLOGY,9,11. |
MLA | Li, Longfei,et al."A Non-invasive Radiomic Method Using F-18-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With Glioma".FRONTIERS IN ONCOLOGY 9(2019):11. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论